Abstract

Research Article

Single-center experience in sutureless aortic valve implantation using two aortic valve prostheses

Laura Rings, Vasileios Ntinopoulos, Stak Dushaj, Gojart Hoti, Philine Fleckenstein, Omer Dzemali* and Achim Häussler#

Published: 22 July, 2022 | Volume 7 - Issue 2 | Pages: 056-060

Background and aim of the study: Sutureless aortic valves are used to reduce operation time. However, the stent implantation might cause postoperative ECG alterations and a higher risk of paravalvular leakage. In literature, some cases of thrombocytopenia are described after implantation. We investigated the Sorin Perceval S Sutureless Valve and the Edwards Intuity Sutureless Valve.
Material and methods: Seventy-nine patients underwent aortic valve replacement using a sutureless valve in a single center between 2015 - 2018. Thirty-seven patients received Sorin Perceval S (Group A) and 42 Edwards Intuity (Group B). Simultaneous bypass surgery was performed in 23 patients in Group A and 22 patients in Group B. We compared the groups regarding postoperative TTE and paravalvular leakage, postoperative ECG alterations, need for pacemaker implantation, postoperative platelet count, and 30-day mortality
Results: Only in Group B 2 patients had paravalvular leakage, and one was reoperated within the same hospital stay. In Group A, nine patients suffered from postoperative atrial fibrillation, and in Group B, 16 patients. Left bundle branch block (LBBB) was observed in 5 patients in Group A, and 13 patients in Group B. Two patients in Group A needed a definite pacemaker, and five patients in Group B. Tachy-Brady Syndrome and LBBB were observed more frequently in Group B as well as ECG alterations. One patient died within 30 days in Group A due to multiorgan failure. This patient was older and multimorbid compared to the average. Regarding platelet count, we saw a statistically significant decrease in both groups. There were no major bleeding complications or reoperations due to hemorrhage.
Conclusion: Our data shows that sutureless aortic valve replacement is associated with new postoperative ECG alterations, which are self-limiting in most cases. Compared to the literature pacemaker implantation rate in Group B is higher.

Read Full Article HTML DOI: 10.29328/journal.jccm.1001134 Cite this Article Read Full Article PDF

References

  1. Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med. 1999 Jul 15;341(3):142-7. doi: 10.1056/NEJM199907153410302. PMID: 10403851.
  2. Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, Capodanno D, Conradi L, De Bonis M, De Paulis R, Delgado V, Freemantle N, Gilard M, Haugaa KH, Jeppsson A, Jüni P, Pierard L, Prendergast BD, Sádaba JR, Tribouilloy C, Wojakowski W; ESC/EACTS Scientific Document Group. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur J Cardiothorac Surg. 2021 Oct 22;60(4):727-800. doi: 10.1093/ejcts/ezab389. Erratum in: Eur J Cardiothorac Surg. 2022 Mar 24;61(4):964. Erratum in: Eur J Cardiothorac Surg. 2022 Jun 15;62(1): PMID: 34453161.
  3. Kvidal P, Bergström R, Hörte LG, Ståhle E. Observed and relative survival after aortic valve replacement. J Am Coll Cardiol. 2000 Mar 1;35(3):747-56. doi: 10.1016/s0735-1097(99)00584-7. PMID: 10716479.
  4. Jakobsen L, Terkelsen CJ, Søndergaard L, De Backer O, Aarøe J, Nissen H, Johnsen SP, Christiansen EH. Short- and Long-Term Mortality and Stroke Risk After Transcatheter Aortic Valve Implantation. Am J Cardiol. 2018 Jan 1;121(1):78-85. doi: 10.1016/j.amjcard.2017.09.014. Epub 2017 Oct 10. Erratum in: Am J Cardiol. 2018 Feb 1;121(3):395. PMID: 29103605.
  5. D'Onofrio A, Salizzoni S, Filippini C, Tessari C, Bagozzi L, Messina A, Troise G, Tomba MD, Rambaldini M, Dalén M, Alamanni F, Massetti M, Mignosa C, Russo C, Salvador L, Di Bartolomeo R, Maselli D, De Paulis R, Alfieri O, De Filippo CM, Portoghese M, Bortolotti U, Rinaldi M, Gerosa G. Surgical aortic valve replacement with new-generation bioprostheses: Sutureless versus rapid-deployment. J Thorac Cardiovasc Surg. 2020 Feb;159(2):432-442.e1. doi: 10.1016/j.jtcvs.2019.02.135. Epub 2019 May 11. PMID: 31213376.
  6. Laborde F, Fischlein T, Hakim-Meibodi K, Misfeld M, Carrel T, Zembala M, Madonna F, Meuris B, Haverich A, Shrestha M; Cavalier Trial Investigators. Clinical and haemodynamic outcomes in 658 patients receiving the Perceval sutureless aortic valve: early results from a prospective European multicentre study (the Cavalier Trial)†. Eur J Cardiothorac Surg. 2016 Mar;49(3):978-86. doi: 10.1093/ejcts/ezv257. Epub 2015 Aug 4. PMID: 26245628.
  7. Kocher AA, Laufer G, Haverich A, Shrestha M, Walther T, Misfeld M, Kempfert J, Gillam L, Schmitz C, Wahlers TC, Wippermann J, Mohr FW, Roth M, Skwara A, Rahmanian P, Wiedemann D, Borger MA. One-year outcomes of the Surgical Treatment of Aortic Stenosis With a Next Generation Surgical Aortic Valve (TRITON) trial: a prospective multicenter study of rapid-deployment aortic valve replacement with the EDWARDS INTUITY Valve System. J Thorac Cardiovasc Surg. 2013 Jan;145(1):110-5; discussion 115-6. doi: 10.1016/j.jtcvs.2012.07.108. Epub 2012 Oct 8. PMID: 23058665.
  8. Ranucci M, Frigiola A, Menicanti L, Castelvecchio S, de Vincentiis C, Pistuddi V. Aortic cross-clamp time, new prostheses, and outcome in aortic valve replacement. J Heart Valve Dis. 2012 Nov;21(6):732-9. PMID: 23409353.
  9. Di Eusanio M, Phan K. Sutureless aortic valve replacement. Ann Cardiothorac Surg. 2015 Mar;4(2):123-30. DOI: 10.3978/j.issn.2225-319X.2015.02.06. PMID: 25870807; PMCID: PMC4384242.
  10. Di Eusanio M, Phan K, Berretta P, Carrel TP, Andreas M, Santarpino G, Di Bartolomeo R, Folliguet T, Meuris B, Mignosa C, Martinelli G, Misfeld M, Glauber M, Kappert U, Shrestha M, Albertini A, Teoh K, Villa E, Yan T, Solinas M. Sutureless and Rapid-Deployment Aortic Valve Replacement International Registry (SURD-IR): early results from 3343 patients. Eur J Cardiothorac Surg. 2018 Oct 1;54(4):768-773. doi: 10.1093/ejcts/ezy132. PMID: 29617925.
  11. Hanedan MO, Mataracı İ, Yürük MA, Özer T, Sayar U, Arslan AK, Ziyrek U, Yücel M. Early Outcomes of Sutureless Aortic Valves. Korean J Thorac Cardiovasc Surg. 2016 Jun;49(3):165-70. doi: 10.5090/kjtcs.2016.49.3.165. Epub 2016 Jun 5. PMID: 27298793; PMCID: PMC4900858.
  12. Liakopoulos OJ, Gerfer S, Rahmanian P, Eghbalzadeh K, Djordjevic I, Schlachtenberger G, Zeriouh M, Mader N, Choi YH, Wahlers T. Rapid Deployment Aortic Valve Replacement with the Perceval S and Intuity Elite. Thorac Cardiovasc Surg. 2021 Aug;69(5):412-419. doi: 10.1055/s-0040-1716892. Epub 2020 Oct 25. PMID: 33099764.
  13. Shrestha M, Folliguet T, Meuris B, Dibie A, Bara C, Herregods MC, Khaladj N, Hagl C, Flameng W, Laborde F, Haverich A. Sutureless Perceval S aortic valve replacement: a multicenter, prospective pilot trial. J Heart Valve Dis. 2009 Nov;18(6):698-702. PMID: 20099720.
  14. Minh TH, Mazine A, Bouhout I, El-Hamamsy I, Carrier M, Bouchard D, Demers P. Expanding the indication for sutureless aortic valve replacement to patients with mitral disease. J Thorac Cardiovasc Surg. 2014 Oct;148(4):1354-9. doi: 10.1016/j.jtcvs.2013.12.061. Epub 2014 Jan 15. PMID: 25260274.
  15. Laufer G, Haverich A, Andreas M, Mohr FW, Walther T, Shrestha M, Rahmanian P, Holzhey D, Roth M, Schmitz C, Schramm R, Giot C, Wahlers TCW. Long-term outcomes of a rapid deployment aortic valve: data up to 5 years. Eur J Cardiothorac Surg. 2017 Aug 1;52(2):281-287. doi: 10.1093/ejcts/ezx103. PMID: 28453629.
  16. Laborde F, Fischlein T, Hakim-Meibodi K, Misfeld M, Carrel T, Zembala M, Madonna F, Meuris B, Haverich A, Shrestha M; Cavalier Trial Investigators. Clinical and haemodynamic outcomes in 658 patients receiving the Perceval sutureless aortic valve: early results from a prospective European multicentre study (the Cavalier Trial)†. Eur J Cardiothorac Surg. 2016 Mar;49(3):978-86. doi: 10.1093/ejcts/ezv257. Epub 2015 Aug 4. PMID: 26245628.
  17. Popma JJ, Deeb GM, Yakubov SJ, Mumtaz M, Gada H, O'Hair D, Bajwa T, Heiser JC, Merhi W, Kleiman NS, Askew J, Sorajja P, Rovin J, Chetcuti SJ, Adams DH, Teirstein PS, Zorn GL 3rd, Forrest JK, Tchétché D, Resar J, Walton A, Piazza N, Ramlawi B, Robinson N, Petrossian G, Gleason TG, Oh JK, Boulware MJ, Qiao H, Mugglin AS, Reardon MJ; Evolut Low-Risk Trial Investigators. Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients. N Engl J Med. 2019 May 2;380(18):1706-1715. DOI: 10.1056/NEJMoa1816885. Epub 2019 Mar 16. PMID: 30883053.
  18. Mack MJ, Leon MB, Thourani VH, Makkar R, Kodali SK, Russo M, Kapadia SR, Malaisrie SC, Cohen DJ, Pibarot P, Leipsic J, Hahn RT, Blanke P, Williams MR, McCabe JM, Brown DL, Babaliaros V, Goldman S, Szeto WY, Genereux P, Pershad A, Pocock SJ, Alu MC, Webb JG, Smith CR; PARTNER 3 Investigators. Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients. N Engl J Med. 2019 May 2;380(18):1695-1705. doi: 10.1056/NEJMoa1814052. Epub 2019 Mar 16. PMID: 30883058.
  19. Carrel T, Heinisch PP. History, development and clinical perspectives of sutureless and rapid deployment surgical aortic valve replacement. Ann Cardiothorac Surg. 2020 Sep;9(5):375-385. doi: 10.21037/acs-2020-surd-18. PMID: 33102176; PMCID: PMC7548211.
  20. Shrestha M, Fischlein T, Meuris B, Flameng W, Carrel T, Madonna F, Misfeld M, Folliguet T, Haverich A, Laborde F. European multicentre experience with the sutureless Perceval valve: clinical and haemodynamic outcomes up to 5 years in over 700 patients. Eur J Cardiothorac Surg. 2016 Jan;49(1):234-41. doi: 10.1093/ejcts/ezv040. Epub 2015 Mar 6. PMID: 25750010.
  21. Jiritano F, Cristodoro L, Malta E, Mastroroberto P. Thrombocytopenia after sutureless aortic valve implantation: Comparison between Intuity and Perceval bioprostheses. J Thorac Cardiovasc Surg. 2016 Dec;152(6):1631-1633. doi: 10.1016/j.jtcvs.2016.07.054. Epub 2016 Aug 4. PMID: 27575240.
  22. Lorusso R, Jiritano F, Roselli E, Shrestha M, Folliguet T, Meuris B, Pollari F, Fischlein T; PERSIST-AVR Investigators. Perioperative platelet reduction after sutureless or stented valve implantation: results from the PERSIST-AVR controlled randomized trial. Eur J Cardiothorac Surg. 2021 Dec 1;60(6):1359-1365. doi: 10.1093/ejcts/ezab175. PMID: 34118150.

Figures:

Figure 1

Figure 1

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Help ?